EPS for Medical Transcription Billing, Corp. (MTBC) Expected At $-0.09 as of May, 9

April 17, 2018 - By Robert Reynolds

Medical Transcription Billing, Corp. (NASDAQ:MTBC) Corporate Logo
Big Money Sentiment decreased to 1.2 in Q4 2017. It has change of 1.05, from 2017Q3’s 2.25. The ratio fall due to Medical Transcription Billing, Corp. positioning: 2 sold and 3 reduced. 4 funds amassed positions and 2 increased positions. Investors holded 222,021 in 2017Q3 but now own 267,513 shares or 20.49% more.
10,825 were reported by Virtu Fincl Lc. Moreover, Qci Asset has 0.01% invested in Medical Transcription Billing, Corp. (NASDAQ:MTBC) for 19,158 shs. Morgan Stanley holds 250 shs. Panagora Asset Management reported 0% in Medical Transcription Billing, Corp. (NASDAQ:MTBC). Susquehanna Int Grp Llp accumulated 12,514 shs. Geode Mngmt Ltd Liability owns 30,694 shs. Deutsche Bankshares Ag reported 2,500 shs or 0% of all its holdings. The Maryland-based Price T Rowe Md has invested 0% in Medical Transcription Billing, Corp. (NASDAQ:MTBC). Pennsylvania-based Vanguard Group has invested 0% in Medical Transcription Billing, Corp. (NASDAQ:MTBC). Burns J W And Communication New York accumulated 0.01% or 14,158 shs.

Medical Transcription Billing, Corp. registered $436,474 net activity with 0 insider purchases and 2 sales since March 26, 2018. On Monday, March 26 SNYDER STEPHEN ANDREW sold $208,744 worth of Medical Transcription Billing, Corp. (NASDAQ:MTBC) or 8,250 shs.

Earnings report for Medical Transcription Billing, Corp. (NASDAQ:MTBC) is expected On May, 9., Faxor reports. Analysts have anticipation on stock’s earnings per share of $-0.09. That’s up 25.00 % from last year’s $-0.12 earnings per share. Last quarter $0.04 earnings per share was reported. Analysts sees -325.00 % negative EPS growth this quarter. Its shares touched $3.33 on during the last trading session after 0.60% change.Currently Medical Transcription Billing, Corp. is uptrending after 384.29% change in last April 17, 2017. MTBC has also 106,988 shares volume. The stock outperformed the S&P500 by 372.74%.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) Ratings Coverage

Total analysts of 2 have positions in Medical Transcription (NASDAQ:MTBC) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since November 14, 2017 according to StockzIntelligence Inc Medical Transcription has 2 analyst reports. On Tuesday, November 14 the firm earned “Buy” rating by Chardan Capital Markets.

Medical Transcription Billing, Corp., a healthcare information technology company, provides an integrated suite of Web solutions and related business services to healthcare providers primarily in the United States.The company has $38.85 million market cap. It principally offers PracticePro, a software-as-a-service platform, which includes practice management solutions and related tools that facilitate the day-to-day operation of a medical practice; electronic health record solutions, which enables clients to reduce paperwork and qualify for government incentives; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services.Last it reported negative earnings. The firm also provides ChartsPro, a Web EHR solution; transcription, coding, indexing, and other ancillary services; clearinghouse services, which enables clients to track claim status and includes batch electronic claim and payment transaction clearing services, as well as Web access for claim corrections; and electronic data interchange management system that audits, manages, and controls the exchange of information.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.